10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001513160-13-000061`
Period End Date	20130331
Filing Date	20131023
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	gnpb-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 43 Cash Flow Statement 98 Stockholders Equity 8

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.87K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$8.91K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.27K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.15K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.28K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.15K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	18.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $10,870 and $8,915	`PropertyPlantAndEquipmentNet`	$22.14K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $10,870 and $8,915	`PropertyPlantAndEquipmentNet`	$20.18K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	18.00M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	818,806.00	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	818,806.00	shares	Point-in-time
Total assets	`Assets`	$28.33K	USD	Point-in-time
Total assets	`Assets`	$29.41K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	818,806.00	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	818,806.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.29M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.74M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.86M	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	$1.23M	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	$1.23M	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	$250.00K	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	$250.00K	USD	Point-in-time
18% secured convertible promissory note	`SecuredConvertiblePromissoryNote`	-	USD	Point-in-time
18% secured convertible promissory note	`SecuredConvertiblePromissoryNote`	$300.00K	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.37M	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.03M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.31M	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 818,806 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$34.00	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 818,806 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$34.00	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-31.73M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.68M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-12.28M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$29.41K	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$28.33K	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	22 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$1.23M	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$16.22M	USD	22 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$87.39K	USD	1 Quarter
Operating expenses (including $87,386, $1,227,227, and $16,224,743 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$26.93M	USD	22 Qtrs
Operating expenses (including $87,386, $1,227,227, and $16,224,743 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$434.91K	USD	1 Quarter
Operating expenses (including $87,386, $1,227,227, and $16,224,743 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$2.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$886.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$270.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.85M	USD	22 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	22 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.14M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$30.95M	USD	22 Qtrs
Total costs and expenses	`OperatingExpenses`	$704.91K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-704.91K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-30.95M	USD	22 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.14M	USD	1 Quarter
Interest expense	`InterestExpense`	$341.62K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.41M	USD	22 Qtrs
Interest expense	`InterestExpense`	$88.47K	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$10.00M	USD	22 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-2.55M	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.50M	USD	22 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts`	$2.87M	USD	22 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.64M	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-784.69K	USD	22 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-341.62K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-31.73M	USD	22 Qtrs
Net Loss	`NetIncomeLoss`	$-5.77M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.05M	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$7.39	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$1.28	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	818,806.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	781,367.00	shares	1 Quarter

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-31.73M	USD	22 Qtrs
Net loss	`NetIncomeLoss`	$-5.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.05M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.55K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.96K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$72.24K	USD	22 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	22 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.18M	USD	1 Quarter
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$87.39K	USD	1 Quarter
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$4.52M	USD	22 Qtrs
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	$2.99M	USD	22 Qtrs
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	1 Quarter
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	1 Quarter
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	$2.56M	USD	22 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	1 Quarter
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	1 Quarter
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.00M	USD	22 Qtrs
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts1`	$385.00K	USD	22 Qtrs
Private placement costs	`PrivatePlacementCosts1`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts1`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$2.55M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-10.00M	USD	22 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	1 Quarter
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	22 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$50.00K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.30M	USD	22 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	1 Quarter
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	22 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	1 Quarter
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	1 Quarter
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	22 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	1 Quarter
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-20.19K	USD	1 Quarter
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-8.15K	USD	22 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-875.00	USD	1 Quarter
Bank overdraft	`ProceedsFromBankDebt`	-	USD	22 Qtrs
Bank overdraft	`ProceedsFromBankDebt`	$17.62K	USD	1 Quarter
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$5.53M	USD	22 Qtrs
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$658.06K	USD	1 Quarter
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$372.18K	USD	1 Quarter
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	-	USD	1 Quarter
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	$866.00K	USD	1 Quarter
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	-	USD	22 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-760.22K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-300.00K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.42M	USD	22 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$35.05K	USD	22 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	1 Quarter
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	22 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	1 Quarter
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-85.05K	USD	22 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$300.00K	USD	1 Quarter
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$6.40M	USD	22 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.09M	USD	22 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.00K	USD	1 Quarter
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	22 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	1 Quarter
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$300.00K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$250.00K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$9.51M	USD	22 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-510.22K	USD	1 Quarter
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	22 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$182.08K	USD	1 Quarter
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	1 Quarter
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	22 Qtrs
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	1 Quarter
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$1.90M	USD	22 Qtrs
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	22 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	1 Quarter
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	22 Qtrs

Stockholders Equity 8 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$-12.28M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Fair value of vested stock options	`ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue`	$87.39K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-31.73M	USD	22 Qtrs
Net loss	`NetIncomeLoss`	$-5.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.05M	USD	1 Quarter
Ending Balance Amount	`StockholdersEquity`	$-12.28M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.